Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

Industry Veteran Matthew Cranfill, RN, BSN, WOCN, Will Lead the Company's NPWT Clinical Support & Education.

Matthew Cranfill, RN, BSN, WOCN, has been named as Director of Clinical Services reports ExtriCare USA today.

Matthew Cranfill will oversee ExtriCARE USA’s clinical services, focusing on product development and wound care education. With over 23 years of clinical experience and a distinguished track record in wound healing, Cranfill will take ExtriCARE USA’s clinical program to the next level.

“Matt’s impressive experience and skillset easily made him our top pick,” said Peter Mason, President of ExtriCARE USA. “His eagerness to innovate and hands-on approach deeply aligns with our company vision. Matt brings tremendous value to our expanding team, and I’m excited about the impact he will have on our future growth.”

Combining his extensive background and passion for wound healing, Cranfill brings the dedication and leadership necessary to drive ExtriCARE USA’s clinical services. He has a keen eye for figuring out how to improve patient outcomes and clinician satisfaction.

“I’m thrilled to be joining ExtriCARE USA’s forward-thinking team at such a pivotal time in wound care,” said Cranfill. “There’s a lot of potential for growth and innovation in the NPWT market, and I look forward to applying my clinical perspective to enhance the outcomes for the clients, clinicians and patients who use our products.”

ExtriCARE USA firmly believes in NPWT’s potential and is proactively investing in its future. The company is cultivating a strong network of dealers who will have direct clinical support and educational resources. ExtriCARE USA’s goal is to boost the growth and success of NPWT, optimizing clinician satisfaction and the patient healing experience.

Looking ahead, ExtriCARE USA will be launching new portable, powerful and adaptive NPWT solutions to the market.

 

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.